Alticor sales data has been released, with a slight drop from $6.4 billion to $6.3 billion. As expected, sales in China decreased substantially, indeed by nearly a quarter, meaning a loss of revenue of more than half a billion US dollars. This was offset by 42% growth in Amway Europe (led by the new markets of Amway Russia and Amway Ukraine) and continued strong sales throughout Asia.

Interestingly, we're still awaiting Quixtar sales data – however we know it continues to be more than a billion and there were increased numbers of qualifiers at Achieve.

I'm "offline" for much of the next few days, keep an eye out for the new Quixtar Opportunity Zone.

Post a comment below or Discuss this post on Amway Talk